AbbVie Inc. (ABBV) Operating margin 2016–2025
AbbVie Inc. (ABBV) operating margin by fiscal year — reported operating income divided by reported revenue.
24.6%FY2025 · since FY2016: 36.4% → 24.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 24.6% | +8.4 pp |
| FY2024 | 16.2% | -7.3 pp |
| FY2023 | 23.5% | -7.7 pp |
| FY2022 | 31.2% | -0.7 pp |
| FY2021 | 31.9% | +7.1 pp |
| FY2020 | 24.8% | -14.2 pp |
| FY2019 | 39.0% | +19.5 pp |
| FY2018 | 19.5% | -14.3 pp |
| FY2017 | 33.8% | -2.6 pp |
| FY2016 | 36.4% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More ABBV financial trends
ABBV RevenueABBV Net incomeABBV Net marginABBV Gross profitABBV Gross marginABBV Operating incomeABBV Operating cash flowABBV Free cash flowABBV Capital expendituresABBV Return on equityABBV Stock buybacksABBV Dividends paidABBV Total assetsABBV Total liabilitiesABBV Shareholders’ equityABBV overview →